Article
Pharmacology & Pharmacy
Fawaz Alasmari, Mohammed S. Alasmari, Hussa Mubarak Muwainea, Hatun A. Alomar, Abdullah F. Alasmari, Sary Alsanea, Aws Alshamsan, Muhammad F. Rasool, Faleh Alqahtani
Summary: In this study, a physiologically-based pharmacokinetic (PBPK) model was used as a tool for precision dosing to predict the biological exposure of ceftriaxone in healthy and chronic kidney disease patients. The model successfully described the pharmacokinetic behavior of ceftriaxone in both populations and suggested dose adjustments for patients with renal impairment.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Pharmacology & Pharmacy
Ye Xiong, Tomoyuki Mizuno, Ruben Colman, Jeffrey Hyams, Joshua D. Noe, Brendan Boyle, Yi-Ting Tsai, Min Dong, Kimberly Jackson, Nieko Punt, Michael J. Rosen, Lee A. Denson, Alexander A. Vinks, Phillip Minar
Summary: The study identified blood biomarkers for rapid clearance and exposure targets of infliximab in pediatric Crohn's disease. Higher AUC during induction was associated with better treatment outcomes and lower surgery rates for patients.
CLINICAL PHARMACOLOGY & THERAPEUTICS
(2021)
Article
Gastroenterology & Hepatology
Anne S. Strik, Mark Lowenberg, Diane R. Mould, Sophie E. Berends, Cyriel Ponsioen, Jan M. H. van den Brande, Jeroen M. Jansen, Daniel R. Hoekman, Johannan F. Brandse, Marjolijn Duijvestein, Krisztina B. Gecse, Annick de Vries, Ron A. Mathot, Geert R. D'Haens
Summary: In IBD patients, using a Bayesian dashboard for IFX dosing can reduce the incidence of LOR and lower fecal calprotectin levels. Additionally, this method can increase the proportion of patients in sustained clinical remission.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
(2021)
Article
Infectious Diseases
Ute Chiriac, Daniel C. Richter, Otto R. Frey, Anka C. Roehr, Sophia Helbig, Judit Preisenberger, Stefan Hagel, Jason A. Roberts, Markus A. Weigand, Alexander Brinkmann
Summary: Optimizing antibiotic dosing through software-guided empiric dosing and therapeutic drug monitoring can enhance therapeutic exposure of piperacillin in critically ill patients with sepsis and septic shock, leading to improved clinical outcomes and reduced mortality rates.
Article
Microbiology
Praneeth Jarugula, Ayse Akcan-Arikan, Flor Munoz-Rivas, Brady S. Moffett, Vijay Ivaturi, Danielle Rios
Summary: This study aimed to determine the optimal vancomycin starting dose regimens in infants <= 180 days of age to achieve the highest probability of target attainment with AUC(24) of >= 400. It also examined the relationship between serum creatinine and vancomycin clearance in neonates.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2022)
Review
Pharmacology & Pharmacy
Hui-Yin Yow, Kayatri Govindaraju, Audrey Huili Lim, Nusaibah Abdul Rahim
Summary: In the era of Bad Bugs, No Drugs, optimizing antibiotic therapy against multi-drug resistant (MDR) pathogens is crucial. Mathematical modelling has played an important role in personalized antibiotic treatment.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Pharmacology & Pharmacy
Jessica M. Conway, Pia Abel zur Wiesch
Summary: The antiviral drug remdesivir has been approved for treating COVID-19 by regulatory bodies, but its efficacy and toxicity concerns have sparked debates. Computational models are being used to predict drug efficacy and balancing it with toxicity, particularly due to the complexities of its metabolization. Studies suggest that optimizing dosing regimens and combining remdesivir with other antivirals could potentially enhance efficacy and prevent resistance.
Article
Gastroenterology & Hepatology
Meghan Gibson, Shova Subedi, David H. Barker, Samuel Masur, Meaghan M. Mallette, Archana Lingannan, Aldo Alejandro Recinos Soto, Dyadin Esharif, Sarah H. Maxwell, Muhammad Safwan Riaz, Michael I. Herzlinger, Linda B. Shalon, Carolina S. Cerezo, Vania L. Kasper, Albert M. Ross, Neal S. Leleiko, Jason M. Shapiro
Summary: Objective: To assess the long-term safety and durability of Infliximab (IFX) treatment in pediatric inflammatory bowel disease (IBD). Results: Only 12% of patients discontinued IFX treatment and the majority of adverse events (AEs) were mild and did not result in cessation of therapy. Higher dose and serum trough level of IFX were associated with a higher risk of AEs. Conclusions: IFX has excellent treatment durability in pediatric IBD with low AEs rate and can be safely used for long-term treatment.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
(2023)
Article
Pharmacology & Pharmacy
Celine Konecki, Catherine Feliu, Yoann Cazaubon, Delphine Giusti, Marcelle Tonye-Libyh, Hedia Brixi, Guillaume Cadiot, Amelie Biron, Zoubir Djerada
Summary: This study evaluated eight pharmacokinetic models of infliximab for external validation, showing significant performance variations among the models. Models A and B demonstrated satisfactory results, while highlighting potential areas for improvement.
Article
Chemistry, Physical
Julie A. Harris, Ruibin Liu, Vinicius Martins de Oliveira, Erik Antonio Vazquez-Montelongo, Jack A. Henderson, Jana Shen
Summary: In this study, we developed and validated a GPU-accelerated all-atom continuous constant pH MD method for predicting protonation states in proteins. By using the particle-mesh Ewald (PME) electrostatics in the Amber22 pmemd.cuda engine, we were able to accurately predict pKa values for Asp, Glu, His, and Cys. The method was tested on six benchmark proteins and showed good agreement with experimental results. We also demonstrated that increasing the simulation box size can improve the accuracy of the predictions.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION
(2022)
Article
Infectious Diseases
Anxiong Huang, Feng Mao, Lingli Huang, Shuyu Xie, Yuanhu Pan, Wei Qu, Guyue Cheng, Zhenli Liu, Zonghui Yuan, Dapeng Peng, Haihong Hao
Summary: This study developed a dosing regimen for acetylkitasamycin to treat Streptococcus suis infection through pharmacokinetic-pharmacodynamic modeling. The regimen can effectively treat the infection and slow down the emergence of drug resistance.
Article
Infectious Diseases
Yuran Cao, Yi Li, Beining Guo, Jing Zhang, Xiaojie Wu, Jicheng Yu, Guoying Cao, Yaxin Fan, Hailan Wu
Summary: This study evaluated the pharmacokinetics of levornidazole in healthy subjects and patients, and proposed an evidence-based sequential dosing regimen. Monte Carlo simulation was used to evaluate four dosing regimens. The simulations showed that satisfactory treatment outcomes were achieved for all four regimens when the minimum inhibitory concentration (MIC) was less than or equal to 1 mg/L.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
(2023)
Article
Immunology
Marjorie Z. Imperial, Jerry R. Nedelman, Francesca Conradie, Rada M. Savic
Summary: Limited information is available about optimal linezolid dosing strategies in patients with tuberculosis. We provide practical recommendations about linezolid dosing to minimize severe adverse events.
CLINICAL INFECTIOUS DISEASES
(2022)
Review
Infectious Diseases
Kelly L. Maguigan, Mohammad H. Al-Shaer, Charles A. Peloquin
Summary: Beta-lactam antibiotics are the cornerstone for treating Gram-negative infections in critically ill patients, however, dosing adjustments may be necessary due to the unique physiology and increasing resistance rates in the ICU setting. Continuous infusions are often required to achieve desired pharmacokinetic/pharmacodynamic targets, especially when dealing with less-susceptible pathogens such as Pseudomonas aeruginosa.
Article
Oncology
Claire C. Villette, David Orrell, Jim Millen, Christophe Chassagnole
Summary: Most pharmaceutical products are approved based on their effect in patients who represent the average population in registrational trials, with limited room for dose reduction in case of toxicity. This article explores the evidence supporting personalized dosing in cancer treatment and demonstrates how optimizing the dose, including increasing it, can significantly improve efficacy outcomes. It also discusses the obstacles in implementing personalized dosing in real-world settings, using a personalized dosing platform for docetaxel treatment in prostate cancer as an example.
FRONTIERS IN ONCOLOGY
(2023)
Meeting Abstract
Health Care Sciences & Services
Sabiha Kazi, Amy Kelley, Carla Boutin, Neha Nagpal, Michelle Mendiolaza
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
(2016)
Editorial Material
Gastroenterology & Hepatology
Serre-Yu Wong, Rebekah Dixon, Vicky Martinez Pazos, Sacha Gnjatic, Jean-Frederic Colombel, Ken Cadwell
Article
Psychiatry
Jordyn H. Feingold, Halley Kaye-Kauderer, Michelle Mendiolaza, Marla C. Dubinsky, Laurie Keefer, Ksenia Gorbenko
Summary: This study used photovoice and semi-structured interviews to explore perspectives on IBD care transitions among adolescents and their parents. Both adolescents and parents tended to overestimate the adolescents' resilience and IBD-related self-efficacy, with parents also overestimating their children's abilities. Barriers included psychological distress, disease uncertainty, and gut-brain axis-related issues, while facilitators included positivity, social support, and mental health support.
JOURNAL OF PSYCHOSOMATIC RESEARCH
(2021)